Therapeutic use of aryl amino acid derivatives

Details Therapeutic use of aryl amino acid derivatives Therapeutic use of aryl amino acid derivatives

2006-05-30

2006-05-30

Price, Elvis O. (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S654000, C424S200100, C562S433000

Reexamination Certificate

active

07053122

ABSTRACT:
The compounds of formula (I)are useful in the treatment of faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, neuropathic pain, neuropathological disorders and sleep disorders. Processes for the preparation of the final products and intermediates useful in the process are included. Pharmaceutical compositions containing one or more of the compounds are also included.

REFERENCES:
patent: 4024175 (1977-05-01), Satzinger et al.
patent: 4087554 (1978-05-01), Haydock et al.
patent: WO 95-31194 (1995-11-01), None
patent: WO 95/31194 (1995-11-01), None
Gee, N et al, “The Novel Anticonvusant Drug, Gabapentin (Neurontin), Binds to the Alpha. 2 Delta Subunit of a Calcium Channel”, Journal of Biological Chemistry, Mar. 8, 1996, pp. 5768-5776, vol. 27, No. 10 Baltimore, MD, US.

Affiliated with

Also associated with

Rating

Therapeutic use of aryl amino acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic use of aryl amino acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of aryl amino acid derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3576259